The different effects of cyclosporin A and rapamycin on regulatory CD4+CD25+ T cells: Potential relationship with transplant tolerance induction

Expert Review of Clinical Immunology

Volumn 3, Issue 3, 2007, Pages 245-249

  Zhao, Yong ^a  

^a INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; BASILIXIMAB; CALCINEURIN INHIBITOR; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN A; INTERLEUKIN 10; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; CD4+ CD25+ T LYMPHOCYTE; DRUG MECHANISM; DRUG MEGADOSE; EDITORIAL; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION TOLERANCE;

EID: 34249687073     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.3.3.245     Document Type: Editorial

References (44)

1. Shapiro R, Young JB, Milford EL, Trotter JF, Bustami RT, Leichtman AB. Immunosuppression: evolution in practice and trends, 1993-2003. Am. J. Transplant. 5, 874-886 (2005).
2. Nashan B. Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors. Transpl. Int. 17, 279-285 (2004).
3. Chan L, Gaston R, Hariharan S. Evolution of immunosuppression and continued importance of acute rejection in renal transplantation. Am. J. Kidney Dis. 38, S2-S9 (2001).
4. Land W, Vincenti F. Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation. Transplantation 80, S221-S234 (2005).
5. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3, 199-2 10 (2003).
6. Cobbold SP, Adams E, Graca L et al. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol. Rev. 213, 239-255 (2006).
7. Aluvihare VR, Betz AG. The role of regulatory T cells in alloantigen tolerance. Immunol. Rev. 212, 330-343 (2006).
8. + regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection. Transplantation 82, 1202-1209 (2006).
9. Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723-735 (2005).
10. Nelson B H. IL-2, regulatory T cells, and tolerance. J. Immunol. 172, 3983-3988 (2004).
11. + regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc. Natl Acad. Sci. USA 102, 17418-17423 (2005).
12. + regulatory T cells. J. Immunol. 171, 3348-3352 (2003).
13. + regulatory cells. J. Immunol. 176, 3321-3329 (2006).
14. + memory T cells. J. Immunol. 171, 5853-5864 (2003).
15. Zhao Y. The two simultaneously occurring processes in one immune response: the positive immune reaction and immune tolerance. Med. Hypotheses 67, 1384-1385 (2006).
16. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8-27 (2006).
17. + regulatory T cells and immune tolerance. Autoimmunity 39, 269-276 (2006).
18. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080-1086 (2002).
19. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9, 1144-1150 (2003).
20. + T cells via a CD30-dependent mechanism. J. Clin. Invest. 113, 310-317 (2004).
21. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
22. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30, 1538-1543 (2000).
23. + regulatory T-cells inhibit the islet innate immune response and promote islet engraftment. Diabetes 55, 1011-1021 (2006).
24. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
25. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
26. Zhang L, Zhao Y. The regulation of Foxp3 expression in regulatory CD4(+)CD25(+) T cells: multiple pathways on the road. J. Cell. Physiol. 211, 590-597 (2007).
27. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151 (2005).
28. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6, 1152-1159 (2005).
29. Wang H, Zhao L, Sun Z, Sun L, Zhang B, Zhao Y. A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice. Transplantation 82, 1484-1492 (2006).
30. Shibutani S, Inoue F, Aramaki O et al. Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen. Transplantation 79, 904-913 (2005).
31. Kawai M, Kitade H, Mathieu C, Waer MJ. Pirenne. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation 79, 1073-1077 (2005).
32. Smith CR, Mohanakumar T, Shimizu Y et al. Brief cyclosporine treatment prevents intrathyrnic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model. Transplantation 69, 294-299 (2000).
33. Blaha P, Bigenzahn S, Koporc Z et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 101, 2886-2893 (2003).
34. Taylor PA, Lees CJ, Wilson JM et al. Combined effects ofcalcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. Blood 100, 3400-3407 (2002).
35. Gao W, Oukka M, Kuchroo V, Strom TB. Contrasting effects of cyclosporin and rapamycin in de novo generation of alloantigen-stimulated regulatory T cells. Transplantation 82, 79 (2006).
36. + regulatory T cells in renal transplant recipients. Transplantation 82, 550-557 (2006).
37. Baan CC, van der Mast BJ, Klepper M et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 80, 110-117 (2005).
38. Qu Y, Zhang B, Zhao L et al. The effect of immunosuppressive drug rapamycin on regulatory CD4(+)CD25(+)Foxp3(+) T cells in mice. Transpl. Immunol. 17, 153-161 (2007).
39. + T cells in the periphery. Transplantation 77, 183-189 (2004).
40. + regulatory T cells. Blood 105, 4743-4748 (2005).
41. + regulatory T cells. Blood 107, 1018-1023 (2006).
42. + regulatory T cells cultured with rapamycin. J. Immunol. 178, 320-329 (2007).
43. + T cells. J. Immunol. 177, 944-949 (2006).
44. Battaglia M, Stabilini A, Draghici E et al. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55, 40-49 (2006).